Richard Emmons

He advises individual inventors, companies of all sizes, and academic institutions working in the life sciences, medical device, and mechanical art areas on various IP matters. Richard combines a strong entrepreneurial spirit, an extensive interdisciplinary research experience, and a deep knowledge of the law to counsel clients in the preparation and prosecution of U.S. and foreign patents in the life sciences, medical device, and mechanical art areas. He assists clients with IP due diligence, IP licensing, and patentability, infringement, validity, and freedom-to-operate analyses. His areas of expertise include protein and small molecule pharmaceuticals, antibody therapeutics, vaccines, gene therapy vehicles, constructs, and delivery systems, stem cell-based technologies, biological imaging, medical devices, microfluidics, and biofuels.

Richard has helped clients protect inventions involving protein, antibody, and small molecule therapeutics, mRNA- and protein-based vaccines, gene therapy (vehicles, constructs, and delivery systems), nutraceuticals, genetic engineering, genomics, tissue regeneration and organogenesis, stem cell-based technologies, model system screening assays for gene and drug discovery, nucleic acid – and protein chip-based technologies, bioinformatics analysis, nanobiotechnology, biological imaging, medical devices, microfluidics, and biofuels.

Richard has nearly two decades of research experience spanning developmental biology, genetics, epigenetics, microbiology, cell biology, and computational biology, which included a post-doctoral fellowship in the Department of Genetics at the Harvard Medical School that studied epigenetic mechanisms of gene regulation.